Skip to main navigation Skip to search Skip to main content

A novel targeted approach to deliver treatable trait-based precision medicine for obstructive sleep apnoea

  • Eckert, Danny (Chief Investigator)
  • Grunstein, Ronald R. (Chief Investigator)
  • D'Rozario, Angela (Primary Chief Investigator)
  • Hoyos, Camilla (Chief Investigator)
  • Vakulin, Andrew (Chief Investigator)
  • Adams, Robert (Chief Investigator)
  • Phillips, Craig (Chief Investigator)
  • Chai-Coetzer, Ching Li (Chief Investigator)
  • Yee, Brendon (Chief Investigator)
  • Bidargaddi, Niranjan (Chief Investigator)
  • Lechat, Bastien (Chief Investigator)
  • Mukherjee, Sutapa (Chief Investigator)
  • Wong, Keith (Chief Investigator)
  • Dutta, Ritaban (Associate Investigator)
  • Niland, John (Associate Investigator)
  • White, Alison (Associate Investigator)
  • Green, Timothy (Associate Investigator)
  • Kaambwa, Billingsley (Associate Investigator)
  • Mackay, Stuart (Associate Investigator)
  • Donegan, Michelle (Associate Investigator)
  • Naismith, Sharon (Associate Investigator)
  • Gordon, Christopher (Associate Investigator)
  • Rudge, Sian (Associate Investigator)

Project: Research

Project Details

Description

>1 million Australians have obstructive sleep apnoea (OSA). In addition to disrupted sleep, OSA has serious health, safety, & economic consequences. Current treatment approaches do not consider an individual’s specific needs leading to patient frustration and significant untreated disease. Our research program will generate new diagnostic and clinical tools to provide a range of effective personalised alternative OSA targeted treatments to improve patient health and satisfaction.
Short titleOSA Treatable Traits
AcronymMRFF- Flinders led
StatusActive
Effective start/end date1/03/23 → 29/02/28